ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only

Rhea-AI Summary

ProtoKinetix, a clinical-stage biomedical company, will hold its Annual General Meeting (AGM) virtually on February 11, 2022, at 4:00 p.m. EST. This decision was made due to ongoing COVID-19 concerns, with no in-person attendance permitted. Shareholders are encouraged to review the definitive proxy materials filed with the Securities and Exchange Commission on December 30, 2021. For more details, shareholders can visit www.virtualshareholdermeeting.com/PKTX2022.

Positive

• The AGM provides shareholders with the opportunity to participate in corporate governance remotely.

Negative

• The virtual format limits direct shareholder engagement, which may affect transparency and shareholder relations.

MARIETTA, Ohio--(BUSINESS WIRE)-- ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that it will hold its Annual General Meeting of the Stockholders of the Company (“AGM”) virtually with no option to attend the AGM in person due to ongoing COVID-19 concerns.

As set forth in the Company’s definitive proxy materials as filed with the Securities and Exchange Commission on December 30, 2021, the AGM will be held on Friday, February 11, 2022 at 4:00 p.m. Eastern Standard Time, via webcast at: www.virtualshareholdermeeting.com/PKTX2022.

If you have not received your proxy package, please contact the Company directly:

Clarence E. Smith
President and Chief Executive Officer
Telephone: 740-434-5041
Email: csmith@protokinetix.com

About ProtoKinetix, Incorporated

Cautionary Note Regarding Forward-Looking Statements

The information discussed in this press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical facts, included herein concerning, among other things, planned capital expenditures, future cash flows and borrowings, pursuit of potential acquisition opportunities, our financial position, business strategy and other plans and objectives for future operations, are forward looking statements. Although we believe that the expectations reflected in these forward-looking statements are reasonable, they do involve certain assumptions, risks and uncertainties and are not (and should not be considered to be) guarantees of future performance. Refer to our risk factors set forth in our reports filed on Edgar. ProtoKinetix disclaims any obligation to update any forward-looking statement made here.

This press release does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220114005374/en/

Clarence E. Smith

President and Chief Executive Officer

Telephone: 740-434-5041

Email: csmith@protokinetix.com

Twitter: @ProtoKinetix

Source: ProtoKinetix, Incorporated

FAQ

When is the ProtoKinetix Annual General Meeting?

The ProtoKinetix AGM will be held on February 11, 2022, at 4:00 p.m. EST.

How can I attend the ProtoKinetix AGM?

The AGM will be held virtually; you can attend via webcast at www.virtualshareholdermeeting.com/PKTX2022.

What is the reason for holding the AGM virtually?

The AGM is being held virtually due to ongoing COVID-19 concerns.

Where can I find the proxy materials for ProtoKinetix AGM?

The definitive proxy materials can be found on the Securities and Exchange Commission's website, filed on December 30, 2021.